LifeSteps Financial’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367K Buy
121,965
+3,103
+3% +$8.78K 0.17% 71
2026
Q1
$288K Buy
118,862
+787
+0.7% +$2.15K 0.18% 75
2025
Q4
$515K Buy
118,075
+12,904
+12% +$69.7K 0.33% 47
2025
Q3
$442K Buy
105,171
+7,952
+8% +$28.2K 0.28% 57
2025
Q2
$279K Buy
97,219
+11,627
+14% +$30.7K 0.19% 75
2025
Q1
$231K Sell
85,592
-1,378
-2% -$5.17K 0.19% 75
2024
Q4
$205K Buy
86,970
+8,715
+11% +$23.2K 0.16% 79
2024
Q3
$185K Buy
78,255
+11,719
+18% +$25.8K 0.15% 82
2024
Q2
$130K Buy
66,536
+22,227
+50% +$75.5K 0.11% 78
2024
Q1
$285K Buy
44,309
+9,301
+27% +$84.5K 0.22% 65
2023
Q4
$490K Buy
35,008
+2,191
+7% +$34.6K 0.44% 44
2023
Q3
$804K Buy
32,817
+19,438
+145% +$493K 0.82% 28
2023
Q2
$438K Buy
+13,379
New +$376K 0.43% 43

Other funds holding GNLX

LifeSteps Financial's GNLX Position: Q2 2026 in Review

LifeSteps Financial increased its Genelux (GNLX) stake by 2.6% in Q2 2026, buying an estimated $8.78K and bringing the position to 121,965 shares worth $367K. The position accounts for 0.17% of the portfolio, ranked #71.

LifeSteps Financial first reported a position in GNLX in Q2 2023 and has held it in 13 quarters since. The position peaked at $804K in Q3 2023. 21 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • LifeSteps Financial held 121,965 shares of Genelux worth $367K as of Q2 2026.
  • LifeSteps Financial bought 3,103 Genelux shares in Q2 2026, an estimated $8.78K.
  • Genelux made up 0.17% of LifeSteps Financial's portfolio in Q2 2026, its #71 holding.
  • LifeSteps Financial first reported a position in Genelux in Q2 2023 and has held it in 13 quarters since.
  • LifeSteps Financial's Genelux position peaked at $804K in Q3 2023.
  • 21 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.